On April 1, 2022 Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, reported that management will participate in upcoming investor conferences (Press release, Zymeworks, APR 1, 2022, View Source [SID1234611345]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2022 Biotech Forum. Zymeworks will participate in one-on-one meetings on April 12th in Palm Beach Gardens, FL.

Bloom Burton & Co. Healthcare Investor Conference. Zymeworks will participate in one-on-one meetings and will present on May 2nd at 2:00 p.m. ET.

The presentation will be webcast live with dial-in details and webcast replays available on Zymeworks’ website at View Source